Porcika Klinika
- Address
- Nagy Sándor u.11, 6800 Hodmezovasarhely, Hungary
Porcika Klinika - Rheumatology and Spondyloarthritis Research Center
Porcika Klinika is a specialized medical research facility dedicated to advancing the understanding and treatment of rheumatological conditions, with particular expertise in inflammatory spinal disorders. The center focuses on evaluating innovative therapeutic approaches for patients suffering from chronic inflammatory diseases affecting the musculoskeletal system.
- Axial spondyloarthritis clinical trials and treatment development
- Phase 3 efficacy studies for novel anti-inflammatory medications
- Assessment of targeted therapies for inflammatory spine conditions
The research team at Porcika Klinika specializes in comprehensive evaluation of signs and symptoms in patients with active inflammatory conditions, utilizing rigorous Phase 3 study protocols. Their commitment to evidence-based medicine and participation in international multi-center trials positions them as a key contributor to advancing treatment options for patients with axial spondyloarthritis and related inflammatory disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Elevara Medicines Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Porcika Klinika
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis | Alfasigma S.p.A. | Phase III | Not Recruiting | Jun 2023 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Filgotinib | 1 | Unknown | 2023-06-21 | 2023-06-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.